Study ID: EV3 Durablilty PAS CP-1001
Description:

The US StuDy for EvalUating EndovasculaR TreAtments of Lesions in the Superficial Femoral Artery and Proximal Popliteal By usIng the Protégé EverfLex NitInol STent SYstem Post Approval Study (DURABILITY PAS)

Location:
Sioux Falls Region
Principal Investigator:
Greg Schultz, MD
Disease:
Stage:
Post Marketing

Status:

Active - Open to Accrual

For more information, call or email Bismarck Clinical Research at (701) 323-5760, Fargo and Bemidji Clinical Research at (701) 234-5890, or Sioux Falls Clinical Research at (605) 328-1368.

Back to Clinical Trials list